Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
about
Drug bioactivation, covalent binding to target proteins and toxicity relevance.Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective studyAntioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection.Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology.
P2860
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@ast
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@en
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@nl
type
label
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@ast
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@en
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@nl
prefLabel
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@ast
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@en
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@nl
P1476
Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
@en
P2093
Joel E Lavine
Silvia Buratti
P304
P356
10.1097/00008480-200210000-00007
P577
2002-10-01T00:00:00Z